Herti 150 Mg Injection

HERTI is a monoclonal antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers It is specifically used for cancer that is HER2 receptor positive It may be used by itself or together with other chemotherapy medication. HERTI is given by slow injection into a vein and injection just under the skin.

Some side effects may occur during the injection, or in the days afterward. Tell your caregiver right away if you feel dizzy, nauseated, itchy, light-headed, weak, short of breath, or if you have a headache, fever, chills, or chest pain. Common side effects include fever, infection, cough, headache, trouble sleeping, and rash. Other severe side effects include heart failure, allergic reactions, and lung disease.

Do not use HERTI if you are pregnant. trastuzumab can cause injury or death to the unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 7 months after your last dose.

Tell your doctor if you become pregnant. If you become pregnant while using trastuzumab or within 7 months after you stop, your name may be listed on a pregnancy registry to track the effects of trastuzumab on the baby.

It may not be safe to breastfeed while using this medicine and for up to 7 months after your last dose. Ask your doctor about any risk.

Given as an infusion into a vein. A healthcare provider will give you this injection and usually given once every week or every 1 to 3 weeks. Follow your doctor's dosing instructions very carefully. This medicine must be given slowly, and the infusion can take up to 90 minutes to complete. You may need frequent medical tests to be sure this medicine is not causing harmful effects. Your cancer treatments may be delayed based on the results.